Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AZN Astrazeneca	$183.36 +1.0%	$190.49	$137.23 ▼ $212.71	$281.57B	0.25	1.78 million shs	1.96 million shs
AZNCF AstraZeneca	$187.10	$187.10	$122.26 ▼ $195.00	N/A	N/A	1,957 shs	N/A
INTU Intuit	$293.78 -3.8%	$372.58	$291.18 ▼ $813.70	$83.57B	0.98	6.62 million shs	4.92 million shs
SGHC Super Group (SGHC)	$13.34 +3.6%	$12.30	$8.46 ▼ $14.38	$6.51B	1.08	3.63 million shs	6.82 million shs
WIX Wix.com	$48.22 +0.0%	$67.45	$46.90 ▼ $190.93	$2.81B	0.91	2.59 million shs	1.77 million shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AZN Astrazeneca	+0.85%	+3.39%	+0.36%	-5.15%	+25.57%
AZNCF AstraZeneca	0.00%	0.00%	0.00%	0.00%	+27.70%
INTU Intuit	-3.84%	-8.80%	-25.87%	-33.30%	-61.57%
SGHC Super Group (SGHC)	+3.50%	+5.13%	+2.07%	+22.83%	+44.41%
WIX Wix.com	+0.02%	-15.51%	-39.82%	-46.37%	-68.68%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AZN Astrazeneca	$183.36 +1.0%	$190.49	$137.23 ▼ $212.71	$281.57B	0.25	1.78 million shs	1.96 million shs
AZNCF AstraZeneca	$187.10	$187.10	$122.26 ▼ $195.00	N/A	N/A	1,957 shs	N/A
INTU Intuit	$293.78 -3.8%	$372.58	$291.18 ▼ $813.70	$83.57B	0.98	6.62 million shs	4.92 million shs
SGHC Super Group (SGHC)	$13.34 +3.6%	$12.30	$8.46 ▼ $14.38	$6.51B	1.08	3.63 million shs	6.82 million shs
WIX Wix.com	$48.22 +0.0%	$67.45	$46.90 ▼ $190.93	$2.81B	0.91	2.59 million shs	1.77 million shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AZN Astrazeneca	+0.85%	+3.39%	+0.36%	-5.15%	+25.57%
AZNCF AstraZeneca	0.00%	0.00%	0.00%	0.00%	+27.70%
INTU Intuit	-3.84%	-8.80%	-25.87%	-33.30%	-61.57%
SGHC Super Group (SGHC)	+3.50%	+5.13%	+2.07%	+22.83%	+44.41%
WIX Wix.com	+0.02%	-15.51%	-39.82%	-46.37%	-68.68%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AZN Astrazeneca	2.85	Moderate Buy	$205.33	11.98% Upside
AZNCF AstraZeneca	0.00	N/A	N/A	N/A
INTU Intuit	2.72	Moderate Buy	$514.58	75.16% Upside
SGHC Super Group (SGHC)	2.78	Moderate Buy	$17.57	31.76% Upside
WIX Wix.com	2.50	Moderate Buy	$98.45	104.17% Upside

Current Analyst Ratings Breakdown

Latest SGHC, WIX, INTU, AZN, and AZNCF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/9/2026	WIX Wix.com	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
6/9/2026	WIX Wix.com	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/9/2026	WIX Wix.com	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Equal Weight	$54.00 ➝ $47.00
6/9/2026	WIX Wix.com	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Sector Perform	$60.00 ➝ $45.00
6/9/2026	AZN Astrazeneca	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/9/2026	AZN Astrazeneca	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell
6/9/2026	AZN Astrazeneca	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/9/2026	WIX Wix.com	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$66.00 ➝ $59.00
6/8/2026	WIX Wix.com	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Sector Outperform	$110.00 ➝ $90.00
6/8/2026	WIX Wix.com	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sector Perform
6/2/2026	INTU Intuit	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$519.00 ➝ $276.00

(Data available from 6/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AZN Astrazeneca	$58.74B	4.84	$13.06 per share	14.04	$31.41 per share	5.84
AZNCF AstraZeneca	N/A	N/A	N/A	N/A	N/A	N/A
INTU Intuit	$18.83B	4.27	$17.79 per share	16.51	$75.42 per share	3.90
SGHC Super Group (SGHC)	$2.23B	3.02	$0.74 per share	18.14	$1.58 per share	8.44
WIX Wix.com	$1.99B	1.41	$4.36 per share	11.07	($6.66) per share	-7.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AZN Astrazeneca	$10.23B	$6.66	27.53	17.15	1.56	17.19%	30.86%	12.68%	7/27/2026 (Estimated)
AZNCF AstraZeneca	N/A	$0.82	229.29	N/A	N/A	N/A	N/A	N/A	N/A
INTU Intuit	$3.87B	$16.51	17.79	13.94	1.12	21.91%	25.18%	13.79%	8/20/2026 (Estimated)
SGHC Super Group (SGHC)	$217M	$0.48	27.61	14.98	N/A	10.58%	42.85%	26.15%	N/A
WIX Wix.com	$50.65M	-$0.78	N/A	30.14	N/A	-1.97%	-33.28%	2.84%	8/5/2026 (Estimated)

Latest SGHC, WIX, INTU, AZN, and AZNCF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/20/2026	Q3 2026	INTU Intuit	$12.57	$12.80	+$0.23	$11.09	$8.54 billion	$8.56 billion
5/13/2026	Q1 2026	WIX Wix.com	$1.21	$0.68	-$0.53	-$1.02	$544.04 million	$541.17 million
5/11/2026	Q1 2026	SGHC Super Group (SGHC)	$0.1743	$0.17	-$0.0043	$0.1710	$584.75 million	$612.00 million
4/29/2026	Q1 2026	AZN Astrazeneca	$2.52	$2.58	+$0.06	$0.9850	$14.93 billion	$15.29 billion
4/18/2026	Q1 2026	SGHC Super Group (SGHC)	N/A	$0.13	N/A	$0.1330	N/A	$578.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AZN Astrazeneca	$4.34	2.37%	+2.30%	65.17%	N/A
AZNCF AstraZeneca	$2.80	1.50%	N/A	343.14%	N/A
INTU Intuit	$4.80	1.63%	+14.43%	29.07%	13 Years
SGHC Super Group (SGHC)	$0.20	1.50%	N/A	41.67%	N/A
WIX Wix.com	N/A	N/A	N/A	N/A	N/A

Latest SGHC, WIX, INTU, AZN, and AZNCF Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/19/2026	INTU Intuit	quarterly	$1.20	1.56%	7/9/2026	7/9/2026	7/17/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AZN Astrazeneca	0.52	0.91	0.71
AZNCF AstraZeneca	N/A	N/A	N/A
INTU Intuit	0.26	1.45	1.45
SGHC Super Group (SGHC)	0.02	1.61	1.61
WIX Wix.com	N/A	1.71	1.71

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AZN Astrazeneca	20.35%
AZNCF AstraZeneca	40.87%
INTU Intuit	83.66%
SGHC Super Group (SGHC)	5.09%
WIX Wix.com	81.52%

Insider Ownership

Company	Insider Ownership
AZN Astrazeneca	N/A
AZNCF AstraZeneca	N/A
INTU Intuit	2.49%
SGHC Super Group (SGHC)	10.41%
WIX Wix.com	6.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AZN Astrazeneca	96,100	1.55 billion	N/A	N/A
AZNCF AstraZeneca	83,500	N/A	N/A	Not Optionable
INTU Intuit	18,200	273.54 million	266.73 million	Optionable
SGHC Super Group (SGHC)	2,900	505.87 million	453.21 million	Optionable
WIX Wix.com	4,622	58.31 million	54.70 million	Optionable

SGHC, WIX, INTU, AZN, and AZNCF Headlines

Recent News About These Companies

Wix.com faces AI headwinds in web design market: RBC

June 9 at 6:03 PM | seekingalpha.com

Securities Fraud Investigation Into Wix.com Ltd. (WIX) Continues â€“ Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

June 9 at 4:03 PM | businesswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Wix.com Ltd. - WIX

June 9 at 1:37 PM | globenewswire.com

Citigroup Lowers Wix.com (NASDAQ:WIX) Price Target to $59.00

June 9 at 10:48 AM | marketbeat.com

Securities Fraud Investigation Into Wix.com Ltd. (WIX) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

June 9 at 1:30 AM | tmcnet.com

Securities Fraud Investigation Into Wix.com Ltd. (WIX) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R.

June 8 at 4:54 PM | businesswire.com

WIX Stock Drops To Lowest Levels Since January 2017 – Reduction In Revenue, Bookings Guidance Dampen Investor Sentiment

June 8 at 3:29 PM | finance.yahoo.com

Wix stock slides on revenue, bookings warning

June 8 at 3:29 PM | seekingalpha.com

WIX Investors Have Opportunity to Join Wix.com Ltd. Fraud Investigation with the Schall Law Firm

June 8 at 12:29 PM | prnewswire.com

Wix.com (WIX) Stock Plummets 11% Following Major Layoffs and Revised Financial Outlook

June 8 at 11:10 AM | blockonomi.com

Wix Hits 52-Week Lows As Earnings Miss, Mass Layoffs, And AI Fears Pile On

June 8 at 10:31 AM | benzinga.com

Wix.com Slashes 20% of Staff, Lowers Outlook as Restructuring Continues

June 8 at 10:05 AM | wsj.com

When The Bull Case for a Company Starts With “I Wouldn’t Be Surprised If It Goes to Zero,” I Pay Attention

June 8 at 7:31 AM | 247wallst.com

When The Bull Case for a Company Starts With “I Wouldn't Be Surprised If It Goes to Zero,” I Pay Attention

June 8 at 7:21 AM | 247wallst.com

$WIX Securities Notice: BFA Law Notifies Wix Investors of the Pending Securities Fraud Investigation to Recover Losses – Act Now if You Lost Money

June 8 at 6:17 AM | globenewswire.com

Here is Why Wix.com (WIX) is One of the Oversold Stocks to Buy Right Now

June 8 at 1:31 AM | insidermonkey.com

Why The Wix.com (WIX) Story Is Being Rewritten Around AI Spending And Base44 Uncertainty

June 6, 2026 | finance.yahoo.com

WIX.COM INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Wix.com Ltd.

June 5, 2026 | globenewswire.com

$WIX Stock Notification: Lose Money on Your Wix Investment? Contact BFA Law about its Ongoing Securities Fraud Investigation

June 5, 2026 | globenewswire.com

Wix.com (WIX) 27% Drop Prompts Investor Scrutiny - HBSS Investigating Unanticipated Spike in Operating Expenses

June 4, 2026 | prnewswire.com

Wix.com (WIX) Offers Potential With Compressed Valuations

June 4, 2026 | insidermonkey.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SGHC, WIX, INTU, AZN, and AZNCF Company Descriptions

Astrazeneca NYSE:AZN

$183.36 +1.81 (+1.00%)

Closing price 06/9/2026 03:59 PM Eastern

Extended Trading

$183.25 -0.11 (-0.06%)

As of 06/9/2026 07:57 PM Eastern

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

AstraZeneca OTCMKTS:AZNCF

$187.10 0.00 (0.00%)

As of 06/5/2026

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Intuit NASDAQ:INTU

$293.78 -11.73 (-3.84%)

Closing price 06/9/2026 04:00 PM Eastern

Extended Trading

$293.70 -0.08 (-0.03%)

As of 06/9/2026 07:59 PM Eastern

Intuit Inc. provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business & Self-Employed segment provides QuickBooks services, that includes financial and business management online services and desktop software, payroll solutions, time tracking, merchant payment processing solutions, and financing for small businesses; and Mailchimp services, such as e-commerce, marketing automation, and customer relationship management. This segment also offers QuickBooks online services and desktop software solutions comprising QuickBooks Online Advanced, a cloud-based solution; QuickBooks Enterprise, a hosted solution; and QuickBooks Self-Employed solution; payment-processing solutions, including credit and debit cards, Apple Pay, and ACH payment services; and financial supplies and financing for small businesses, as well as electronic filing of federal and state income tax returns. The Consumer segment provides TurboTax income tax preparation products and services. The Credit Karma segment offers consumers with a personal finance platform that provides personalized recommendations of home, auto, and personal loans, as well as credit cards and insurance products. The ProTax segment provides Lacerte, ProSeries, and ProFile desktop tax-preparation software products; and ProConnect Tax Online tax products, electronic tax filing service, and bank products and related services. It sells products and services through various sales and distribution channels, including multi-channel shop-and-buy experiences, websites and call centers, mobile application stores, and retail and other channels. The company was founded in 1983 and is headquartered in Mountain View, California.

Super Group (SGHC) NYSE:SGHC

$13.34 +0.47 (+3.62%)

Closing price 06/9/2026 03:59 PM Eastern

Extended Trading

$12.88 -0.46 (-3.45%)

As of 06/9/2026 06:59 PM Eastern

Super Group (SGHC) Limited operates as an online sports betting and gaming operator. It offers Betway, an online sports betting brand; and Spin, a multi-brand online casino offering. Super Group (SGHC) Limited is based in Saint Peter Port, Guernsey.

Wix.com NASDAQ:WIX

$48.22 +0.01 (+0.02%)

Closing price 06/9/2026 04:00 PM Eastern

Extended Trading

$47.70 -0.52 (-1.07%)

As of 06/9/2026 07:52 PM Eastern

Wix.com Ltd., together with its subsidiaries, operates as a cloud-based web development platform for registered users and creators worldwide. The company offers Wix Editor, a drag-and-drop visual development and website editing environment platform; and Wix ADI that enables users to have the freedom of customization that the classic editor offers. It also provides Wix Logo Maker that generates a logo, including through the use of artificial intelligence; Wix Answers to support users; and Payments by Wix, a payment platform, which helps its users receive payments from their customers through their Wix Website. In addition, the company offers various vertical-specific applications that business owners use to operate various aspects of their business online. Further, it provides a range of complementary services, including Wix App Market, a marketplace that offers its registered users various free and paid web applications for building, growing, and managing their businesses; Wix marketplace that brings users seeking help in creating and managing a website together with Web experts; and Wix owner App, a native mobile application, which enables users to manage their Websites and Wix operating systems. The company was formerly known as Wixpress Ltd. The company was incorporated in 2006 and is headquartered in Tel Aviv, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SGHC, WIX, INTU, AZN, and AZNCF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SGHC, WIX, INTU, AZN, and AZNCF Earnings

Compare Dividends

Latest SGHC, WIX, INTU, AZN, and AZNCF Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SGHC, WIX, INTU, AZN, and AZNCF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SGHC, WIX, INTU, AZN, and AZNCF Company Descriptions

Astrazeneca NYSE:AZN

AstraZeneca OTCMKTS:AZNCF

Intuit NASDAQ:INTU

Super Group (SGHC) NYSE:SGHC

Wix.com NASDAQ:WIX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools